Article
Versatile chimeric antigen receptor platform for controllable and combinatorial T cell therapy
1 Jan 2020
Abstract excerpt
Chimeric antigen receptor (CAR) T cells show remarkable therapeutic effects in some hematological malignancies. However, CAR T cells can also cause life-threatening side effects. In order to minimize off-target and on-target/off-tumor reactions, improve safety, enable controllability, provide high flexibility, and increase tumor specificity, we established a novel humanized artificial receptor platform termed...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
